Accessibility Menu
Biodesix logo

Biodesix

(NASDAQ) BDSX

Current Price$21.04
Market Cap$218.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-92%
5 Year-91%
1 Year+238%
1 Month+40%

Biodesix Financials at a Glance

Market Cap

$218.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$96.10M

Net Income (TTM)

-$31.96M

EPS (TTM)

-$4.03

P/E Ratio

-5.25

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$21.04

Volume

0

Open

$21.47

Previous Close

$21.04

Daily Range

$21.04 - $22.49

52-Week Range

$5.26 - $24.92

Estimated Earnings Date

Aug 6, 2026

BDSX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biodesix

Industry

Healthcare Providers and Services

Employees

334

CEO

Scott Hutton

Headquarters

Boulder, CO 80301, US

BDSX Financials

Key Financial Metrics (TTM)

Gross Margin

82.08%

Operating Margin

-25.91%

Net Income Margin

-33.26%

Return on Equity

-2101.40%

Return on Capital

-39.45%

Return on Assets

-33.77%

Earnings Yield

-19.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$218.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

10.36M

Volume

0

Avg. Volume

76.15K

Financials (TTM)

Gross Profit

$78.88M

Operating Income

-$24.90M

EBITDA

-$18.34M

Operating Cash Flow

-$24.84M

Capital Expenditure

-$411.00K

Free Cash Flow

-$25.25M

Cash & ST Invst.

$25.57M

Total Debt

$71.61M

Biodesix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$25.56M

+42.3%

Gross Profit

$21.35M

+49.8%

Gross Margin

83.55%

N/A

Market Cap

$218.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$655.14K

N/A

Employees

334

N/A

Net Income

-$7.79M

+29.8%

EBITDA

-$4.40M

+45.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$25.57M

+45.3%

Total Debt

$71.61M

+15.0%

Accounts Receivable

$9.50M

+24.4%

Inventory

$0.00

N/A

Long Term Debt

$70.16M

+14.7%

Short Term Debt

$1.45M

+30.8%

Return on Assets

-33.77%

N/A

Return on Invested Capital

-31.07%

N/A

Free Cash Flow

-$10.31M

-18.0%

Operating Cash Flow

-$10.17M

-18.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRSNMersana Therapeutics, Inc.
$29.08+0.00%
XLOXilio Therapeutics, Inc.
$9.03-2.27%
OKUROnKure Therapeutics, Inc.
$4.22+2.68%
INMBINmune Bio, Inc.
$2.02+8.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.63-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$75.02+0.03%
NXTCNextCure
$6.58+2.02%
SOFISoFi Technologies
$18.55+0.02%

Questions About BDSX

What is the current price of Biodesix?

Biodesix is trading at $21.04 per share.

What is the 52-week range for Biodesix?

Over the past 52 weeks, Biodesix has traded between $5.26 and $24.92.

How much debt does Biodesix have?

As of the most recent reporting period, Biodesix reported total debt of $71.61M.

How much cash does Biodesix have on hand?

Biodesix reported $25.67M in cash and cash equivalents in its most recent financial results.

What is Biodesix’s dividend yield?

Biodesix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.